DOA
DXCM icon

D'Orazio & Associates’s DexCom DXCM Stock Holding History

D'Orazio & Associates’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,785
Closed -$1.2M – 290
2025
Q3 		$1.2M Buy
17,785
+6
+0% +$475 0.16% 55
2025
Q2 		$1.55M Buy
17,779
+2,599
+17% +$204K 0.22% 47
2025
Q1 		$1.04M Buy
15,180
+4
+0% +$326 0.16% 57
2024
Q4 		$1.18M Sell
15,176
-1
-0% -$74 0.17% 48
2024
Q3 		$1.02M Sell
15,177
-145
-0.9% -$11.9K 0.14% 57
2024
Q2 		$1.74M Buy
15,322
+2,937
+24% +$371K 0.27% 35
2024
Q1 		$1.72M Buy
12,385
+19
+0.2% +$2.39K 0.28% 33
2023
Q4 		$1.53M Buy
12,366
+93
+0.8% +$9.5K 0.27% 33
2023
Q3 		$1.15M Buy
12,273
+1,355
+12% +$153K 0.26% 39
2023
Q2 		$1.4M Buy
10,918
+4,150
+61% +$502K 0.33% 28
2023
Q1 		$786K Hold
6,768
– – 0.2% 38
2022
Q4 		$766K Hold
6,768
– – 0.18% 43
2022
Q3 		$545K Buy
6,768
+1,548
+30% +$131K 0.16% 50
2022
Q2 		$389K Buy
+5,220
New +$476K 0.1% 72
2022
Q1 		– Sell
-1,548
Closed -$208K – 111
2021
Q4 		$208K Hold
1,548
– – 0.05% 96
2021
Q3 		$212K Buy
+1,548
New +$195K 0.05% 85

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

D'Orazio & Associates's DXCM Position: Q4 2025 in Review

D'Orazio & Associates sold out of DexCom (DXCM) in Q4 2025, closing a stake of 17,785 shares — an estimated $1.2M sold.

D'Orazio & Associates first reported a position in DXCM in Q3 2021 and held it in 16 quarters. The position peaked at $1.74M in Q2 2024. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • D'Orazio & Associates reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • D'Orazio & Associates sold 17,785 DexCom shares in Q4 2025, an estimated $1.2M.
  • D'Orazio & Associates first reported a position in DexCom in Q3 2021 and held it in 16 quarters.
  • D'Orazio & Associates's DexCom position peaked at $1.74M in Q2 2024.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on D'Orazio & Associates's 13F filing for Q4 2025, filed 4 Feb 2026.